Skip to main content

MoneyWorks4Me

The sales is pegged at Rs. 143.03 millions for the September 2023 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 196.23 millions during the year-ago period.The Net Profit of the company vaulted to 153.96% to Rs. 26.59  millions from Rs. 10.47 millions in the previous quarter.OP of the company witnessed a marginal growth to 40.30 millions from 18.53 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 143.03 196.23 -27.11 284.48 335.60 -15.23 650.98 612.14 6.34
Other Income 0.00 0.00 0.00 0.34 5.74 -94.08 34.03 13.81 146.42
PBIDT 40.30 18.53 117.49 79.80 33.02 141.67 79.86 67.59 18.15
Interest 2.82 3.59 -21.45 5.85 6.23 -6.10 12.31 8.77 40.36
PBDT 37.48 14.94 150.87 73.95 26.79 176.04 67.55 58.82 14.84
Depreciation 2.03 0.95 113.68 4.05 2.74 47.81 7.44 7.88 -5.58
PBT 35.45 13.99 153.40 69.90 24.05 190.64 60.11 50.94 18.00
TAX 8.86 3.52 151.70 17.59 6.05 190.74 14.52 11.70 24.10
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -1.41 -1.50 -6.00
PAT 26.59 10.47 153.96 52.31 18.00 190.61 45.59 39.24 16.18
Equity 177.45 126.50 40.28 177.45 126.50 40.28 176.64 126.50 39.64
PBIDTM(%) 28.18 9.44 198.38 28.05 9.84 185.10 12.27 11.04 11.10
Peers
Company Name CMP
Sun Pharma. Inds. 1905.00
Dr. Reddys Labs. 1385.00
Cipla 1406.00
Lupin 2012.00
Zydus Lifesciences 1213.05
View more..